Evidence map›Paper›PMID 32610503›Full record

ReviewNutrients2020

Low Vitamin B12 and Lipid Metabolism: Evidence from Pre-Clinical and Clinical Studies.

Joseph Boachie, Antonysunil Adaikalakoteswari, Jinous Samavat, Ponnusamy Saravanan

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 2 pooled it
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 2 syntheses or guidelines pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Joseph BoachieDivision of Metabolic and Vascular Health, Warwick Medical School, University of Warwick, Coventry CV2 2 DX, UK.ORCID 0000-0003-3950-6423
Antonysunil AdaikalakoteswariDivision of Metabolic and Vascular Health, Warwick Medical School, University of Warwick, Coventry CV2 2 DX, UK.ORCID 0000-0003-2974-3388
Jinous SamavatDivision of Metabolic and Vascular Health, Warwick Medical School, University of Warwick, Coventry CV2 2 DX, UK.
Ponnusamy SaravananDivision of Metabolic and Vascular Health, Warwick Medical School, University of Warwick, Coventry CV2 2 DX, UK.ORCID 0000-0002-9566-2626
University of Warwick · GBGeorge Eliot Hospital · GB

Funding

Chancellor's scholarship for international students, Warwick Medical School N/AGhana Education Trust Fund GC 147/905/01MAMedical Research Council MR/N006232/1 and MR/R020981/1UKRI block grant N/A
6 · The paper itself

Abstract

Obesity is a worldwide epidemic responsible for 5% of global mortality. The risks of developing other key metabolic disorders like diabetes, hypertension and cardiovascular diseases (CVDs) are increased by obesity, causing a great public health concern. A series of epidemiological studies and animal models have demonstrated a relationship between the importance of vitamin B12 (B12) and various components of metabolic syndrome. High prevalence of low B12 levels has been shown in European (27%) and South Indian (32%) patients with type 2 diabetes (T2D). A longitudinal prospective study in pregnant women has shown that low B12 status could independently predict the development of T2D five years after delivery. Likewise, children born to mothers with low B12 levels may have excess fat accumulation which in turn can result in higher insulin resistance and risk of T2D and/or CVD in adulthood. However, the independent role of B12 on lipid metabolism, a key risk factor for cardiometabolic disorders, has not been explored to a larger extent. In this review, we provide evidence from pre-clinical and clinical studies on the role of low B12 status on lipid metabolism and insights on the possible epigenetic mechanisms including DNA methylation, micro-RNA and histone modifications. Although, there are only a few association studies of B12 on epigenetic mechanisms, novel approaches to understand the functional changes caused by these epigenetic markers are warranted.

Indexed as

AdultAnimalsBiomarkersCardiometabolic Risk FactorsChildDNA MethylationEpigenesis, GeneticFemaleHistonesHumansLipid MetabolismMaleMetabolic SyndromeMicroRNAsObesityPregnancyBiomarkersHistonesMicroRNAsVitamin B 12cardiovascular disease (CVD)lipid metabolismmetabolic syndrome (MetS)obesitytype 2 diabetes mellitus (T2D)vitamin B12 (B12)

Identifiers

PMID32610503
PMCPMC7400011
OpenAlexW3037345424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.